SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity

Takeshi Yoshizaki, Simon Schenk, Takeshi Imamura, Jennie Bever, Noriyuki Sonoda, Eun Ju Bae, Da Young Oh, Min Lu, Jill C. Milne, Christoph Westphal, Gautam Bandyopadhyay, Jerrold M. Olefsky

Research output: Contribution to journalArticle

218 Citations (Scopus)

Abstract

Chronic inflammation is an important etiology underlying obesity-related disorders such as insulin resistance and type 2 diabetes, and recent findings indicate that the macrophage can be the initiating cell type responsible for this chronic inflammatory state. The mammalian silent information regulator 2 homolog SIRT1 modulates several physiological processes important for life span, and a potential role of SIRT1 in the regulation of insulin sensitivity has been shown. However, with respect to inflammation, the role of SIRT1 in regulating the proinflammatory pathway within macrophages is poorly understood. Here, we show that knockdown of SIRT1 in the mouse macrophage RAW264.7 cell line and in intraperitoneal macrophages broadly activates the JNK and IKK inflammatory pathways and increases LPS-stimulated TNFα secretion. Moreover, gene expression profiles reveal that SIRT1 knockdown leads to an increase in inflammatory gene expression. We also demonstrate that SIRT1 activators inhibit LPS-stimulated inflammatory pathways, as well as secretion of TNFα, in a SIRT1-dependent manner in RAW264.7 cells and in primary intraperitoneal macrophages. Treatment of Zucker fatty rats with a SIRT1 activator leads to greatly improved glucose tolerance, reduced hyperinsulinemia, and enhanced systemic insulin sensitivity during glucose clamp studies. These in vivo insulin-sensitizing effects were accompanied by a reduction in tissue inflammation markers and a decrease in the adipose tissue macrophage proinflammatory state, fully consistent with the in vitro effects of SIRT1 in macrophages. In conclusion, these results define a novel role for SIRT1 as an important regulator of macrophage inflammatory responses in the context of insulin resistance and raise the possibility that targeting of SIRT1 might be a useful strategy for treating the inflammatory component of metabolic diseases.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume298
Issue number3
DOIs
StatePublished - Mar 1 2010
Externally publishedYes

Fingerprint

Insulin Resistance
Macrophages
Inflammation
Physiological Phenomena
Zucker Rats
Glucose Clamp Technique
Metabolic Diseases
Hyperinsulinism
Transcriptome
Type 2 Diabetes Mellitus
Adipose Tissue
Obesity
Insulin
Gene Expression
Glucose
Cell Line

Keywords

  • Insulin resistance
  • Macrophage

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. / Yoshizaki, Takeshi; Schenk, Simon; Imamura, Takeshi; Bever, Jennie; Sonoda, Noriyuki; Bae, Eun Ju; Oh, Da Young; Lu, Min; Milne, Jill C.; Westphal, Christoph; Bandyopadhyay, Gautam; Olefsky, Jerrold M.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, No. 3, 01.03.2010.

Research output: Contribution to journalArticle

Yoshizaki, T, Schenk, S, Imamura, T, Bever, J, Sonoda, N, Bae, EJ, Oh, DY, Lu, M, Milne, JC, Westphal, C, Bandyopadhyay, G & Olefsky, JM 2010, 'SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity', American Journal of Physiology - Endocrinology and Metabolism, vol. 298, no. 3. https://doi.org/10.1152/ajpendo.00417.2009
Yoshizaki, Takeshi ; Schenk, Simon ; Imamura, Takeshi ; Bever, Jennie ; Sonoda, Noriyuki ; Bae, Eun Ju ; Oh, Da Young ; Lu, Min ; Milne, Jill C. ; Westphal, Christoph ; Bandyopadhyay, Gautam ; Olefsky, Jerrold M. / SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. In: American Journal of Physiology - Endocrinology and Metabolism. 2010 ; Vol. 298, No. 3.
@article{2bde9e083943474e893bfbf009b1f29e,
title = "SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity",
abstract = "Chronic inflammation is an important etiology underlying obesity-related disorders such as insulin resistance and type 2 diabetes, and recent findings indicate that the macrophage can be the initiating cell type responsible for this chronic inflammatory state. The mammalian silent information regulator 2 homolog SIRT1 modulates several physiological processes important for life span, and a potential role of SIRT1 in the regulation of insulin sensitivity has been shown. However, with respect to inflammation, the role of SIRT1 in regulating the proinflammatory pathway within macrophages is poorly understood. Here, we show that knockdown of SIRT1 in the mouse macrophage RAW264.7 cell line and in intraperitoneal macrophages broadly activates the JNK and IKK inflammatory pathways and increases LPS-stimulated TNFα secretion. Moreover, gene expression profiles reveal that SIRT1 knockdown leads to an increase in inflammatory gene expression. We also demonstrate that SIRT1 activators inhibit LPS-stimulated inflammatory pathways, as well as secretion of TNFα, in a SIRT1-dependent manner in RAW264.7 cells and in primary intraperitoneal macrophages. Treatment of Zucker fatty rats with a SIRT1 activator leads to greatly improved glucose tolerance, reduced hyperinsulinemia, and enhanced systemic insulin sensitivity during glucose clamp studies. These in vivo insulin-sensitizing effects were accompanied by a reduction in tissue inflammation markers and a decrease in the adipose tissue macrophage proinflammatory state, fully consistent with the in vitro effects of SIRT1 in macrophages. In conclusion, these results define a novel role for SIRT1 as an important regulator of macrophage inflammatory responses in the context of insulin resistance and raise the possibility that targeting of SIRT1 might be a useful strategy for treating the inflammatory component of metabolic diseases.",
keywords = "Insulin resistance, Macrophage",
author = "Takeshi Yoshizaki and Simon Schenk and Takeshi Imamura and Jennie Bever and Noriyuki Sonoda and Bae, {Eun Ju} and Oh, {Da Young} and Min Lu and Milne, {Jill C.} and Christoph Westphal and Gautam Bandyopadhyay and Olefsky, {Jerrold M.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1152/ajpendo.00417.2009",
language = "English (US)",
volume = "298",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity

AU - Yoshizaki, Takeshi

AU - Schenk, Simon

AU - Imamura, Takeshi

AU - Bever, Jennie

AU - Sonoda, Noriyuki

AU - Bae, Eun Ju

AU - Oh, Da Young

AU - Lu, Min

AU - Milne, Jill C.

AU - Westphal, Christoph

AU - Bandyopadhyay, Gautam

AU - Olefsky, Jerrold M.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Chronic inflammation is an important etiology underlying obesity-related disorders such as insulin resistance and type 2 diabetes, and recent findings indicate that the macrophage can be the initiating cell type responsible for this chronic inflammatory state. The mammalian silent information regulator 2 homolog SIRT1 modulates several physiological processes important for life span, and a potential role of SIRT1 in the regulation of insulin sensitivity has been shown. However, with respect to inflammation, the role of SIRT1 in regulating the proinflammatory pathway within macrophages is poorly understood. Here, we show that knockdown of SIRT1 in the mouse macrophage RAW264.7 cell line and in intraperitoneal macrophages broadly activates the JNK and IKK inflammatory pathways and increases LPS-stimulated TNFα secretion. Moreover, gene expression profiles reveal that SIRT1 knockdown leads to an increase in inflammatory gene expression. We also demonstrate that SIRT1 activators inhibit LPS-stimulated inflammatory pathways, as well as secretion of TNFα, in a SIRT1-dependent manner in RAW264.7 cells and in primary intraperitoneal macrophages. Treatment of Zucker fatty rats with a SIRT1 activator leads to greatly improved glucose tolerance, reduced hyperinsulinemia, and enhanced systemic insulin sensitivity during glucose clamp studies. These in vivo insulin-sensitizing effects were accompanied by a reduction in tissue inflammation markers and a decrease in the adipose tissue macrophage proinflammatory state, fully consistent with the in vitro effects of SIRT1 in macrophages. In conclusion, these results define a novel role for SIRT1 as an important regulator of macrophage inflammatory responses in the context of insulin resistance and raise the possibility that targeting of SIRT1 might be a useful strategy for treating the inflammatory component of metabolic diseases.

AB - Chronic inflammation is an important etiology underlying obesity-related disorders such as insulin resistance and type 2 diabetes, and recent findings indicate that the macrophage can be the initiating cell type responsible for this chronic inflammatory state. The mammalian silent information regulator 2 homolog SIRT1 modulates several physiological processes important for life span, and a potential role of SIRT1 in the regulation of insulin sensitivity has been shown. However, with respect to inflammation, the role of SIRT1 in regulating the proinflammatory pathway within macrophages is poorly understood. Here, we show that knockdown of SIRT1 in the mouse macrophage RAW264.7 cell line and in intraperitoneal macrophages broadly activates the JNK and IKK inflammatory pathways and increases LPS-stimulated TNFα secretion. Moreover, gene expression profiles reveal that SIRT1 knockdown leads to an increase in inflammatory gene expression. We also demonstrate that SIRT1 activators inhibit LPS-stimulated inflammatory pathways, as well as secretion of TNFα, in a SIRT1-dependent manner in RAW264.7 cells and in primary intraperitoneal macrophages. Treatment of Zucker fatty rats with a SIRT1 activator leads to greatly improved glucose tolerance, reduced hyperinsulinemia, and enhanced systemic insulin sensitivity during glucose clamp studies. These in vivo insulin-sensitizing effects were accompanied by a reduction in tissue inflammation markers and a decrease in the adipose tissue macrophage proinflammatory state, fully consistent with the in vitro effects of SIRT1 in macrophages. In conclusion, these results define a novel role for SIRT1 as an important regulator of macrophage inflammatory responses in the context of insulin resistance and raise the possibility that targeting of SIRT1 might be a useful strategy for treating the inflammatory component of metabolic diseases.

KW - Insulin resistance

KW - Macrophage

UR - http://www.scopus.com/inward/record.url?scp=77349087078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77349087078&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00417.2009

DO - 10.1152/ajpendo.00417.2009

M3 - Article

C2 - 19996381

AN - SCOPUS:77349087078

VL - 298

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 3

ER -